Cargando…
Berberine Sensitizes Human Hepatoma Cells to Regorafenib via Modulating Expression of Circular RNAs
Regorafenib resistance is a key limiting factor in the treatment of advanced hepatocellular carcinoma (HCC). Increasing evidence has demonstrated that Berberine (BBR) can synergistically enhance the therapeutic effect of various chemotherapeutic agents. However, the contribution of BBR on regorafeni...
Autores principales: | Wang, Kunyuan, Yu, Ganxiang, Lin, Jiaen, Wang, Zhilei, Lu, Qianting, Gu, Chengxin, Yang, Tao, Liu, Shiming, Yang, Hui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8248669/ https://www.ncbi.nlm.nih.gov/pubmed/34220494 http://dx.doi.org/10.3389/fphar.2021.632201 |
Ejemplares similares
-
Berberine Inhibits Nod-Like Receptor Family Pyrin Domain Containing 3 Inflammasome Activation and Pyroptosis in Nonalcoholic Steatohepatitis via the ROS/TXNIP Axis
por: Mai, Weijian, et al.
Publicado: (2020) -
The Down-Regulation of SUZ12 Accelerates the Migration and Invasion of Liver Cancer Cells via Activating ERK1/2 Pathway
por: Xue, Cailin, et al.
Publicado: (2019) -
LncRNA-AK012226 Is Involved in Fat Accumulation in db/db Mice Fatty Liver and Non-alcoholic Fatty Liver Disease Cell Model
por: Chen, Xingtian, et al.
Publicado: (2018) -
Synergistic antitumor activity of regorafenib and rosuvastatin in colorectal cancer
por: Yuan, Tao, et al.
Publicado: (2023) -
Effects of Berberine on Atherosclerosis
por: Rui, Rui, et al.
Publicado: (2021)